Published in Ann Surg on September 01, 1995
The lost chord: microchimerism and allograft survival. Immunol Today (1996) 2.81
Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg (1998) 2.31
The saga of liver replacement, with particular reference to the reciprocal influence of liver and kidney transplantation (1955-1967). J Am Coll Surg (2002) 1.81
New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients. Clin Microbiol Rev (2000) 1.75
Mucosal damage and recovery of the intestine after prolonged preservation and transplantation in dogs. Transplantation (2001) 1.55
Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both. Transplantation (2000) 1.53
Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg (2001) 1.44
The current status of small bowel transplantation in the UK and internationally. Gut (2005) 1.31
Segmental reversal of the small bowel as an alternative to intestinal transplantation in patients with short bowel syndrome. Ann Surg (1997) 1.28
Graft-versus-host disease after liver and small bowel transplantation in a child. Clin Transplant (1997) 1.09
The effect of sustained delivery of vascular endothelial growth factor on angiogenesis in tissue-engineered intestine. Biomaterials (2008) 1.07
Internal hernia and volvulus of the small bowel following liver transplantation. Transpl Int (1997) 1.02
Concomitant infusion of unmodified donor bone marrow into unconditioned recipients of intestinal allografts. Transplant Proc (1996) 1.00
Protective effect of proteinase-activated receptor 2 activation on motility impairment and tissue damage induced by intestinal ischemia/reperfusion in rodents. Am J Pathol (2006) 0.97
Intestinal transplantation under tacrolimus monotherapy after perioperative lymphoid depletion with rabbit anti-thymocyte globulin (thymoglobulin). Am J Transplant (2005) 0.95
Evolution of clinical intestinal transplantation: improved outcome and cost effectiveness. Transplant Proc (1999) 0.92
Effect of chronic, extrinsic denervation on functional NANC innervation with vasoactive intestinal polypeptide and substance P in longitudinal muscle of rat jejunum. Neurogastroenterol Motil (2007) 0.89
Current status of intestinal transplantation. Surg Today (2010) 0.89
Effects of extrinsic denervation on innervation with VIP and substance P in circular muscle of rat jejunum. Neurogastroenterol Motil (2008) 0.83
Zoom endoscopic monitoring of small bowel allograft rejection. Surg Endosc (2006) 0.82
Upregulation of proapoptotic microRNA mir-125a after massive small bowel resection in rats. Ann Surg (2012) 0.81
Extrinsic denervation causes a transient proabsorptive adrenergic hypersensitivity in the canine proximal colon. Dig Dis Sci (2002) 0.80
The Surgical Approach to Short Bowel Syndrome - Autologous Reconstruction versus Transplantation. Viszeralmedizin (2014) 0.80
Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts. Ann Transplant (1997) 0.79
Extrinsic neural control of nitric oxide synthase expression in the myenteric plexus of rat jejunum. J Physiol (1998) 0.78
Hepatic and intestinal transplantation at the University of Pittsburgh. Clin Transpl (1998) 0.78
Intestinal transplantation in children: five-year experience. Transplant Proc (1996) 0.78
Cold preservation of the human colon and ileum with University of Wisconsin solution. Clin Transplant (1999) 0.78
Small intestine transplantation today. Langenbecks Arch Surg (2007) 0.77
Clinical intestinal transplantation in 1998: Pittsburgh experience. Acta Gastroenterol Belg (1999) 0.77
Modified technique for combined liver-small bowel transplantation in pigs. World J Gastroenterol (2003) 0.77
Improved survival with cytomegalovirus infection after intestinal transplantation in children. Transplant Proc (1996) 0.76
The birth of clinical organ transplantation. J Am Coll Surg (2001) 0.76
The current status of hepatic transplantation at the University of Pittsburgh. Clin Transpl (1995) 0.76
Auxiliary en-bloc liver-small bowel transplantation with partial pancreas preservation in pigs. World J Gastroenterol (2004) 0.75
Multivisceral and small bowel transplantation at shiraz organ transplant center. Int J Organ Transplant Med (2014) 0.75
Isolated small bowel transplantation outcomes and the impact of immunosuppressants: Experience of a single transplant center. World J Transplant (2013) 0.75
Autologous lymphokine-activated killer cell therapy of lymphoproliferative disorders arising in organ transplant recipients. Transplant Proc (1997) 0.75
Intestinal transplantation in 31 adults. Transplant Proc (1996) 0.75
Mechanical elongation of the small intestine: evaluation of techniques for optimal screw placement in a rodent model. Biomed Res Int (2013) 0.75
Effect of CMV serology on outcome after clinical intestinal transplantation. Transplant Proc (1996) 0.75
Long-term function and morphology of intestinal allografts in outbred canine transplantation model. Transplant Proc (2002) 0.75
The mother lode of liver transplantation, with particular reference to our new journal. Liver Transpl Surg (1998) 0.75
Length of transplanted small bowel required for adequate weight gain in rats. Pediatr Surg Int (1997) 0.75
Increased LFA-1 expression in intestines of rats with GVHD after small bowel transplantation. Dig Dis Sci (1998) 0.75
Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet (1979) 12.29
Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24
Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76
The many faces of multivisceral transplantation. Surg Gynecol Obstet (1991) 6.89
Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92
Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg (1989) 5.78
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet (1994) 5.54
Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med (1994) 5.28
Transplantation of small bowel in the rat: technical and immunological considerations. Surgery (1971) 5.05
Intestinal transplantation in composite visceral grafts or alone. Ann Surg (1992) 4.96
Successful small-bowel/liver transplantation. Lancet (1990) 4.85
Homotransplantation of multiple visceral organs. Am J Surg (1962) 4.28
Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12
Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85
Systemic chimerism in human female recipients of male livers. Lancet (1992) 3.63
Transplantation of multiple abdominal viscera. JAMA (1989) 3.59
Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36
Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation (1993) 3.13
The physiological response of the small bowel of the dog to ischemia including prolonged in vitro preservation of the bowel with successful replacement and survival. Ann Surg (1959) 3.10
Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy. Transplant Rev (1971) 2.94
Studies of homograft sex and of gamma globulin phenotypes after orthotopic homotransplantation of the human liver. Surg Forum (1969) 2.80
The use of FK-506 for small intestine allotransplantation. Inhibition of acute rejection and prevention of fatal graft-versus-host disease. Transplantation (1990) 2.79
Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation (1992) 2.75
Epstein-Barr virus strategy in normal and neoplastic B cells. Cell (1994) 2.63
Management of intestinal transplantation in humans. Transplant Proc (1992) 2.62
Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation (1985) 2.34
Three years clinical experience with intestinal transplantation. J Am Coll Surg (1994) 2.20
Transplantation milestones. Viewed with one- and two-way paradigms of tolerance. JAMA (1995) 2.20
Induction of liver, heart, and multivisceral graft acceptance with a short course of FK 506. Transplant Proc (1990) 2.15
Graft-versus-host disease after brown Norway-to-Lewis and Lewis-to-Brown Norway rat intestinal transplantation under FK506. Transplantation (1993) 2.14
Splanchnic transplantation. An approach to the infant dependent on parenteral nutrition who develops irreversible liver disease. JAMA (1989) 2.10
Lymphocyte traffic and graft-versus-host disease after fully allogeneic small bowel transplantation. Transplant Proc (1991) 1.89
Logistics and technique for combined hepatic-intestinal retrieval. Ann Surg (1992) 1.85
Reactions of grafts against their hosts. Science (1959) 1.83
Endotoxaemia, pulmonary complications, and thrombocytopenia in liver transplantation. Lancet (1989) 1.82
Monitoring and treatment of intestinal allograft rejection in humans. Transplant Proc (1993) 1.78
Small intestinal transplantation in humans with or without the colon. Transplantation (1994) 1.74
Successful orthotopic small bowel transplantation with short-term FK 506 immunosuppressive therapy. Transplant Proc (1990) 1.71
Successful small bowel transplantation in an infant. Transplantation (1992) 1.69
Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation. Transplantation (1995) 1.59
Piggyback orthotopic intestinal transplantation. Surg Gynecol Obstet (1993) 1.55
Morphological monitoring of human small bowel allografts. Transplant Proc (1993) 1.52
Studies in small bowel transplantation. Prevention of graft-versus-host disease with preservation of allograft function by donor pretreatment with antilymphocyte serum. Transplantation (1988) 1.52
Multivisceral intestinal transplantation: surgical pathology. Pediatr Pathol (1989) 1.45
Abdominal multivisceral transplantation. Transplantation (1995) 1.37
Spontaneous and iatrogenically augmented leukocyte chimerism in organ transplant recipients. Transplant Proc (1994) 1.29
Endotoxemia and human liver transplantation. Transplant Proc (1989) 1.28
Augmentation of chimerism in whole organ recipients by simultaneous infusion of donor bone marrow cells. Transplant Proc (1995) 1.24
Studies on heterologous antilymphocyte serum in mice. VII. Optimal cellular antigen for induction of immunologic tolerance with antilymphocyte serum. Transplant Proc (1970) 1.22
Successful small intestine transplantation. Transplant Proc (1992) 1.17
Canine small bowel transplantation. A study of the immunological responses. Arch Surg (1976) 1.16
Clinical intestinal transplantation: focus on complications. Transplant Proc (1992) 1.11
Successful multivisceral transplantation. Transplant Proc (1992) 1.09
Nutritional management of intestinal transplant recipients. Transplant Proc (1993) 1.09
The influence of donor and recipient strains in isolated small bowel transplantation in rats. Transplant Proc (1994) 1.04
Lymphoproliferative disease after intestinal transplantation under primary FK 506 immunosuppression. Transplant Proc (1994) 1.03
Graft-versus-host reaction in small bowel transplantation and possibilities for its circumvention. Am J Surg (1986) 1.00
In vitro allograft irradiation prevents graft-versus-host disease in small-bowel transplantation. J Surg Res (1985) 0.97
Effect of pretransplant graft irradiation on canine intestinal transplantation. Surg Gynecol Obstet (1988) 0.95
Endogenous endotoxemia during orthotopic liver transplantation in dogs. Transplant Proc (1989) 0.94
Allografts surviving for 26 to 29 years following living-related kidney transplantation: analysis by light microscopy, in situ hybridization for the Y chromosome, and anti-HLA antibodies. Am J Kidney Dis (1994) 0.90
Prevention of graft-versus-host disease following small bowel transplantation with polyclonal and monoclonal antilymphocyte serum. The effect of timing and route of administration. Transplantation (1991) 0.90
Endorectal pull-through of transplanted colon as part of intestinal transplantation. Surgery (1995) 0.88
Evolution of liver transplantation. Hepatology (1982) 19.54
A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33
Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76
Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11
Kidney transplantation under FK 506. JAMA (1990) 7.45
The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40
The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24
Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19
Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04
Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95
The many faces of multivisceral transplantation. Surg Gynecol Obstet (1991) 6.89
Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64
Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23
Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92
Examination and characterization of distribution system biofilms. Appl Environ Microbiol (1987) 5.85
Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg (1989) 5.78
Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70
Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet (1994) 5.54
Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53
Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44
Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science (2000) 5.38
Occurrence of Giardia and Cryptosporidium spp. in surface water supplies. Appl Environ Microbiol (1991) 5.31
Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24
Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16
Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03
Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01
Intestinal transplantation in composite visceral grafts or alone. Ann Surg (1992) 4.96
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90
Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49
Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32
Inactivation of biofilm bacteria. Appl Environ Microbiol (1988) 4.29
A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29
Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21
Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18
Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16
Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12
Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12
Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08
Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08
Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05
Baboon-to-human liver transplantation. Lancet (1993) 4.01
Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99
Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99
Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91
The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86
Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85
The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84
Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74
Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73
Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66
Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64
Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63
Antitumor agents. 203. Carbazole alkaloid murrayaquinone A and related synthetic carbazolequinones as cytotoxic agents. J Nat Prod (2000) 3.62
Hepatic Retransplantation. Transplant Proc (1985) 3.62
Transplantation of multiple abdominal viscera. JAMA (1989) 3.59
Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57
Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54
Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49
Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40
Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38
The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38
Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34
Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31
Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26
Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24
Changes in blood coagulation. Arch Surg (1966) 3.22
Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18
Renal transplantation in baboons under FK 506. Surgery (1989) 3.17
Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg (1985) 3.17
Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J Exp Med (1995) 3.16
Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol (1985) 3.16
Liver transplantation before 1 year of age. J Pediatr (1987) 3.15
In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs. Transplant Proc (1988) 3.15
The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation (1991) 3.14
Motor responses to sudden limb displacements in primates with specific CNS lesions and in human patients with motor system disorders. Can J Neurol Sci (1975) 3.13
Fungal infections in liver transplant recipients. Transplantation (1985) 3.07
De novo malignant tumors in organ transplant recipients. Transplant Proc (1971) 3.03
Experience with 150 liver resections. Ann Surg (1983) 3.01
A multifactorial system for equitable selection of cadaver kidney recipients. JAMA (1987) 3.01
Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers. N Engl J Med (1988) 3.01
Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy. Ann Surg (1965) 3.00
Death after transplantation; an analysis of sixty cases. Am J Med (1967) 2.99
Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med (1992) 2.98
Biliary tract complications in human orthotopic liver transplantation. Transplantation (1987) 2.95